{
  "docId": "019de073-aaaa-768c-937f-f768840b87a6",
  "docSlug": "9b8664e841ca83938179aa04bf759b1d",
  "documentTitle": "BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides",
  "authorId": "brainstorm-cell-therapeutics",
  "authorName": "Brainstorm Cell Therapeutics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 2,
  "pageCount": 15,
  "prevPage": 1,
  "nextPage": 3,
  "slideType": "preempt_rebuttal",
  "function": "preempt_rebuttal",
  "density": "dense",
  "nDataPoints": 16,
  "notes": "The chart is a dot plot comparing baseline ALSFRS-R scores across various clinical trials, highlighting NurOwn's lower baseline.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de073-aaaa-768c-937f-f768840b87a6/2",
  "deckHref": "/decks/019de073-aaaa-768c-937f-f768840b87a6",
  "deckJsonHref": "/decks/019de073-aaaa-768c-937f-f768840b87a6.json",
  "deckAnchorHref": "/decks/019de073-aaaa-768c-937f-f768840b87a6#slide-2",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.45,
        "x": 0.45,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Dot plot comparing baseline ALSFRS-R scores across different clinical trials",
      "attrs": null,
      "subkind": "dot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ef83ce33-3ffd-4aa0-a6e9-bd6d77cdfe82",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.45,
        "y": 0.12
      },
      "kind": "paragraph",
      "text": "NurOwn Phase 3 featured participants with advanced ALS disease resulting in a floor effect",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3f363490-7c39-461e-a4d9-a88d3d1459f3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.05,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "* Number of participants with baseline ALSFRS-R ≤25 = 44 of 189 (23.3%)",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bb5176dc-5d23-481a-88c7-a80c6500b3e2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.25,
        "x": 0.05,
        "y": 0.3
      },
      "kind": "table",
      "text": "ALSFRS-R Subscale and % participants with value of 0 at baseline",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "854a16a9-0806-4957-a95d-50863aea772e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.05,
        "y": 0.12
      },
      "kind": "title",
      "text": "Participants with baseline ALSFRS-R ≤ 25 are impacted by the floor of the scale",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2a24df53-e993-4cb6-a165-80b0596f9553",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "preempt_rebuttal",
      "slug": null,
      "matchId": "067f8693-0eca-4277-8782-6aa6e96f21ee",
      "evidence": "The slide explicitly addresses a potential criticism (floor effect) to defend trial results.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 3,
      "from": 1,
      "beatId": "9c1c812a-2527-4b8a-941f-7aabfa4ec248",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Problem",
      "beatSlug": "problem-agitate-solution-problem-identify-pain",
      "evidence": "Slides 1-3 introduce the problem and its implications",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 5,
      "from": 2,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "35971733-2689-4bd5-878b-f418c33a2f7c",
      "evidence": "Slides 2-5 discuss the floor effect of the ALSFRS-R scale",
      "position": 1,
      "objective": "Highlight the limitations of current treatments",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}